Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017037

Chief Commercial Officer acquired 35,021 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Yarema Kristin · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-01 Grant or award : show line 1 in the form +35,021 92,289 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-01 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +52,862 52,862 D
Loading xslF345X03/doc4.xml…